Childhood neurodevelopmental outcome in low birth weight infants with postligation cardiac syndrome after ductus arteriosus closure: 5-years follow up

Author(s):  
Maria Carmen BRAVO
PEDIATRICS ◽  
1993 ◽  
Vol 91 (1) ◽  
pp. 164-165
Author(s):  
MARK SALERNO ◽  
MICHAEL ZACKIN ◽  
EVAN CHARNEY

To the Editor.— We are responding to the recent article entitled "Hyperbilirubinemia in Low Birth Weight Infants and Outcome at 5 Years of Age"1 as well as its predecessor "Hyperbilirubinemia in Preterm Infants and Neurodevelopmental Outcome at 2 Years of Age."2 Both articles are equally impressive for the quality of follow-up and the careful analysis of the data. However, there are several questions that merit clarification: 1. Three hundred sixty-one children from the original cohort died within the first 2 years of life, or 27% of the original cohort.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Stefania Longo ◽  
Camilla Caporali ◽  
Camilla Pisoni ◽  
Alessandro Borghesi ◽  
Gianfranco Perotti ◽  
...  

AbstractPreterm very low birth weight infants (VLBWi) are known to be at greater risk of adverse neurodevelopmental outcome. Identifying early factors associated with outcome is essential in order to refer patients for early intervention. Few studies have investigated neurodevelopmental outcome in Italian VLBWi. The aim of our longitudinal study is to describe neurodevelopmental outcome at 24 months of corrected age in an eleven-year cohort of 502 Italian preterm VLBWi and to identify associations with outcome. At 24 months, Griffiths’ Mental Developmental Scales were administered. Neurodevelopmental outcome was classified as: normal, minor sequelae (minor neurological signs, General Quotient between 76 and 87), major sequelae (cerebral palsy; General Quotient ≤ 75; severe sensory impairment). 75.3% showed a normal outcome, 13.9% minor sequelae and 10.8% major sequelae (3.8% cerebral palsy). Male gender, bronchopulmonary dysplasia, abnormal neonatal neurological assessment and severe brain ultrasound abnormalities were independently associated with poor outcome on multivariate ordered logistic regression. Rates of major sequelae are in line with international studies, as is the prevalence of developmental delay over cerebral palsy. Analysis of perinatal complications and the combination of close cUS monitoring and neurological assessment are still essential for early identification of infants with adverse outcome.


Author(s):  
Kousiki Patra ◽  
Michelle M. Greene ◽  
Grace Tobin ◽  
Gina Casini ◽  
Anita L. Esquerra-Zwiers ◽  
...  

1997 ◽  
Vol 97 (4) ◽  
pp. 386-390 ◽  
Author(s):  
STEPHANIE R. BRYSON ◽  
LEA THERIOT ◽  
NELL J. RYAN ◽  
JANET POPE ◽  
NANCY TOLMAN ◽  
...  

PEDIATRICS ◽  
1982 ◽  
Vol 69 (4) ◽  
pp. 463-465
Author(s):  
Gregory L. Johnson ◽  
Nirmala S. Desai ◽  
Thomas H. Pauly ◽  
M. Douglas Cunningham

Eighteen infants, each weighing less than 1,500 gm, were treated with low dose digoxin therapy for patent ductus arteriosus and signs of circulatory congestion. Nine of the 18 developed one or more signs of clinical deterioration felt to be related to digoxin therapy: eight infants experienced frequent episodes of bradycardia, six had cardiac arrhythmias, and six experienced feeding difficulties. All signs disappeared when digoxin therapy was discontinued. Digoxin, even in relatively low dosages, can have deleterious complications in seriously ill low-birth-weight infants. Alternatives to digoxin in this patient population should be considered before institution of digoxin therapy.


Sign in / Sign up

Export Citation Format

Share Document